Analysts Expect Breakeven For Bio-Gate AG (FRA:BIG) Before Long

With the business potentially at an important milestone, we thought we'd take a closer look at Bio-Gate AG's (FRA:BIG) future prospects. Bio-Gate AG provides technologies and customized solutions for health and hygiene in Germany. The €5.0m market-cap company posted a loss in its most recent financial year of €1.2m and a latest trailing-twelve-month loss of €1.3m leading to an even wider gap between loss and breakeven. The most pressing concern for investors is Bio-Gate's path to profitability – when will it breakeven? We've put together a brief outline of industry analyst expectations for the company, its year of breakeven and its implied growth rate.

Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit.

Bio-Gate is bordering on breakeven, according to the 3 German Chemicals analysts. They expect the company to post a final loss in 2027, before turning a profit of €26k in 2028. So, the company is predicted to breakeven approximately 2 years from today. In order to meet this breakeven date, we calculated the rate at which the company must grow year-on-year. It turns out an average annual growth rate of 74% is expected, which is extremely buoyant. If this rate turns out to be too aggressive, the company may become profitable much later than analysts predict.

Underlying developments driving Bio-Gate's growth isn’t the focus of this broad overview, but, keep in mind that generally a high forecast growth rate is not unusual for a company that is currently undergoing an investment period.

Check out our latest analysis for Bio-Gate

Before we wrap up, there’s one aspect worth mentioning. Bio-Gate currently has no debt on its balance sheet, which is quite unusual for a cash-burning growth company, which typically has high debt relative to its equity. The company currently operates purely off its shareholder funding and has no debt obligation, reducing concerns around repayments and making it a less risky investment.

Next Steps:

There are too many aspects of Bio-Gate to cover in one brief article, but the key fundamentals for the company can all be found in one place – Bio-Gate's company page on Simply Wall St. We've also put together a list of important aspects you should further examine:

1. Valuation: What is Bio-Gate worth today? Has the future growth potential already been factored into the price? The intrinsic value infographic in our free research report helps visualize whether Bio-Gate is currently mispriced by the market.
2. Management Team: An experienced management team on the helm increases our confidence in the business – take a look at who sits on Bio-Gate’s board and the CEO’s background.
3. Other High-Performing Stocks: Are there other stocks that provide better prospects with proven track records? Explore our free list of these great stocks here.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.